Beardsley P M, Balster R L
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond.
J Pharmacol Exp Ther. 1988 Jan;244(1):34-40.
The present studies examined whether a variety of drugs representative of diverse pharmacological classes were able to antagonize either the discriminative stimulus or response rate suppressing effects of phencyclidine (PCP). Rats were trained to lever press according to fixed-ratio 32 reinforcement schedules for food pellet delivery and to discriminate PCP from saline vehicle during daily (Monday-Friday) experimental sessions. Drugs combined with PCP to test for antagonism included an alpha-1 (prazosin) and an alpha-2 (yohimbine) adrenergic antagonist, the adenosine receptor agonist, I-phenylisopropyl adenosine, the gamma-aminobutyric acid agonist, imidazole acetic acid, the dopaminergic antagonist, haloperidol, the acylating agent of the PCP receptor, metaphit, and the dopaminergic drugs (+)- and (-)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. All test drugs except metaphit were tested in rats trained to discriminate 2.5 mg/kg of PCP from saline. (+)- and (-)-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine were additionally tested in rats trained to discriminate 1.0 mg/kg of PCP from saline. Metaphit was only tested in rats which had been trained to discriminate a 1.0-mg/kg PCP dose. None of the test drugs systematically reduced PCP level selection to vehicle levels. Yohimbine and prazosin, however, but not the other test drugs, partially reversed the response rate reducing effects of PCP. Evidence that alpha adrenergic antagonists have some PCP antagonistic effects were confirmed for the response rate effects of PCP, indicating a possible role of adrenergic mediation of these effects.
本研究考察了多种代表不同药理类别的药物是否能够拮抗苯环己哌啶(PCP)的辨别刺激或反应率抑制作用。大鼠按照固定比率32强化程序进行训练,以按压杠杆获取食物颗粒,并在每日(周一至周五)实验期间区分PCP和生理盐水。与PCP联合测试拮抗作用的药物包括α-1(哌唑嗪)和α-2(育亨宾)肾上腺素能拮抗剂、腺苷受体激动剂1-苯基异丙基腺苷、γ-氨基丁酸激动剂咪唑乙酸、多巴胺能拮抗剂氟哌啶醇、PCP受体的酰化剂美他西泮以及多巴胺能药物(+)-和(-)-3-(3-羟苯基)-N-(1-丙基)哌啶。除美他西泮外,所有测试药物均在训练区分2.5mg/kg PCP和生理盐水的大鼠中进行测试。(+)-和(-)-3-(3-羟苯基)-N-(1-丙基)哌啶还在训练区分1.0mg/kg PCP和生理盐水的大鼠中进行了额外测试。美他西泮仅在训练区分1.0mg/kg PCP剂量的大鼠中进行了测试。没有一种测试药物能将PCP水平选择系统地降低至生理盐水水平。然而,育亨宾和哌唑嗪,而非其他测试药物,部分逆转了PCP对反应率的降低作用。α肾上腺素能拮抗剂具有一些PCP拮抗作用的证据在PCP对反应率的影响方面得到了证实,表明肾上腺素能介导这些作用可能发挥了作用。